aMoon 2020 Impact Report
Accelerating Cure
We are excited to share the first in what we expect will be an annual series of aMoon Impact reports. The purpose of this annual impact report is to share the progress our portfolio companies are making as they move along the path from innovation to commercialization to societal impact.
At a glance
0
Founded
$
0
B
AUM
0
Team members
0
portfolio companies
0
public companies
0
2020 new investments
medical areas
15
Biopharma
8
Digital health
10
Medtech
9
Tools & diagnostics
Investment Themes
- 51% Personalized & paradigm-shifting treatments
- 31% Engineering biology-using hardware, computer science and engineering to tackle complex biological problems
- 18% The convergence of Big Data and AI- leveraging software, through its predictive power, to triage and diagnose patients
FUNDS
aMoon Growth
Invests in later-stage companies in growth rounds, pre-IPO rounds or in pivotal clinical trials
aMoon Velocity
Invests in companies pursuing disruptive, cutting-edge technologies as early as venture formation through seed/round A